Ticker > Company >

Suraksha Diagnostic share price

Suraksha Diagnostic Ltd.

NSE: SURAKSHA BSE: 544293 SECTOR: Hospital & Healthcare Services  25.87 K   16   9

314.15
-0.05 (-0.02%)
BSE: 22 Aug 04:01 PM

Price Summary

Today's High

₹ 316.3

Today's Low

₹ 310.05

52 Week High

₹ 449

52 Week Low

₹ 233.15

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1636.12 Cr.

Enterprise Value

1626.41 Cr.

No. of Shares

5.21 Cr.

P/E

46.8

P/B

7.31

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  43

CASH

15.53 Cr.

DEBT

5.83 Cr.

Promoter Holding

48.88 %

EPS (TTM)

₹  6.71

Sales Growth

13.99%

ROE

17 %

ROCE

25.83%

Profit Growth

37.14 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year13.99%
3 Year3.73%
5 Year9.6%

Profit Growth

1 Year37.14%
3 Year12.08%
5 Year17.06%

ROE%

1 Year17%
3 Year12.11%
5 Year11.81%

ROCE %

1 Year25.83%
3 Year19.86%
5 Year17.66%

Debt/Equity

0.0272

Price to Cash Flow

26.05

Interest Cover Ratio

5.8459

CFO/PAT (5 Yr. Avg.)

2.46566034883025

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 48.88 0.00
Mar 2025 48.78 0.00
Dec 2024 48.78 0.00
Mar 2023 62.96 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 2.8114 Cr.
  • Company is virtually debt free.
  • The Company has been maintaining an effective average operating margins of 25.60458% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -149.8447 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.46566034883025.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.89662255833797.

 Limitations

  • The company has shown a poor revenue growth of 3.72781060941803% for the Past 3 years.
  • The company is trading at a high PE of 46.8.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 65.95 58.57 64.15 70.28
Total Expenditure 42.37 40.48 44.32 46.44
Operating Profit 23.57 18.09 19.82 23.84
Other Income 1.26 0.98 0.94 1.1
Interest 2.07 2.03 2.06 2.66
Depreciation 8.58 8.62 8.66 9.15
Exceptional Items 0 0 0 0
Profit Before Tax 14.18 8.42 10.04 13.12
Tax 3.43 2.06 2.03 3.27
Profit After Tax 10.75 6.36 8.01 9.85
Adjusted EPS (Rs) 2.49 1.22 1.54 1.89

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 140.01 223.19 189.99 218.52 249.1
Total Expenditure 117.35 175.11 144.5 146.55 165.84
Operating Profit 22.65 48.09 45.49 71.97 83.26
Other Income 1.38 2.3 3.58 3.65 4.38
Interest 1.9 2.1 9.56 9.57 9.05
Depreciation 15.71 15.09 31.63 32.57 34.73
Exceptional Items 0 0 0 -0.78 0
Profit Before Tax 6.41 33.19 7.87 32.71 43.86
Tax -0.06 9.44 0.68 8.32 10.42
Net Profit 6.47 23.75 7.19 24.38 33.44
Adjusted EPS (Rs.) 93.83 344.22 104.19 353.39 6.42

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 8.53 8.53 8.53 8.53 10.42
Total Reserves 117.73 141.49 148.1 172.34 203.9
Borrowings 9.93 12.28 8.43 5.18 2.88
Other N/C liabilities 9.94 10.36 78.96 76.46 77.7
Current liabilities 24.95 28.08 38.04 39.23 38.21
Total Liabilities 171.08 200.74 282.06 301.75 333.1
Assets
Net Block 118.99 119.31 195.05 211.41 215.15
Capital WIP 0.01 1.09 2.39 1.02 5.32
Intangible WIP 0.15 0 0 0 0.49
Investments 0.11 0.16 0.5 1.16 2.71
Loans & Advances 0 9.3 11.42 16.73 29.57
Other N/C Assets 24.51 49.01 5.04 0.68 35.58
Current Assets 27.32 21.86 67.65 70.76 44.27
Total Assets 171.08 200.74 282.06 301.75 333.1
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 6.41 33.19 7.87 32.71 43.86
Adjustment 21.32 15.84 39.65 41.2 41.73
Changes in Assets & Liabilities -2.69 -2.27 4.6 -4.08 -12.21
Tax Paid -1.5 -4.44 -7.19 -8.6 -10.58
Operating Cash Flow 23.54 42.33 44.93 61.23 62.8
Investing Cash Flow -27.71 -43.69 -22.04 -35.04 -39.28
Financing Cash Flow 3.21 1.09 -24.32 -25.83 -24.15
Net Cash Flow -0.96 -0.28 -1.44 0.36 -0.63

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Dec 2024% Mar 2025% Jun 2025%
promoters 62.96 48.78 48.78 48.88
bipul mittal - - - 0.03
dneema overseas private l... - 3.21 3.21 3.21
gopal krishna mittal huf - - - 0.03
late kishan kumar kejriwa... - - - 9.23
ritu mittal - - 15.89 15.89
satish kumar verma - 10.84 10.84 10.84
somnath chatterjee - - 4.99 5.04
tinni investments limited... - 4.62 4.62 4.62
kishan kumar kejriwal 11.15 9.23 9.23 -
ritu mittal 22.87 15.89 - -
somnath chatterjee 9.56 4.99 - -
satish verma 19.38 - - -
total 62.96 - - -
PARTICULARS Mar 2023% Dec 2024% Mar 2025% Jun 2025%
investors 37.04 51.22 51.22 51.12
aditya birla sun life tru... - 3.58 3.58 3.79
bandhan balanced advantag... - 1.13 - 1.33
carnelian bharat amritkaa... - - - 2.41
jm financial mutual fund ... - - - 1.12
kotak small cap fund - 5.00 5.84 5.84
nippon life india trustee... - 5.48 6.09 6.28
orbimed asia ii mauritius... - 12.88 12.88 12.88
quant mutual fund - quant... - 1.52 1.48 1.22
bandhan innovation fund - - 1.34 -
carnelian bharat amritkaa... - 2.10 2.41 -
dneema overseas pvt ltd. 3.87 - - -
munna lal kejriwal 2.56 - - -
orbimed asia ii mauritius... 19.51 - - -
sandip kejriwal 1.06 - - -
santosh kumar kejriwal 4.46 - - -
tinni investment ltd. 5.58 - - -
total 37.04 - - -

Annual Reports

Title Link
Title Link
Annual Report 2025

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
Research Ventura

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q2FY25
Concall Q2FY25
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q2FY25

Company News

Suraksha Diagnostic informs about disclosures 18 Aug, 3:03 PM Suraksha Diagnostic submits press release 9 Aug, 4:00 PM Suraksha Diagnostic - Quaterly Results 8 Aug, 7:45 PM Suraksha Diagnostic - Quaterly Results 8 Aug, 7:45 PM Suraksha Diagnostic launches Genomics Lab in Eastern India 5 Jul, 4:00 PM Suraksha Diagnostic informs about disclosure 25 Jun, 5:34 PM Suraksha Diagnostic to invest Rs 200 crore to set up over 20 centres across eastern India 19 Jun, 11:49 AM Suraksha Diagnostic informs about disclosure 19 Jun, 9:39 AM Suraksha Diagnostic - Quaterly Results 28 May, 7:31 PM Suraksha Diagnostic - Quaterly Results 28 May, 7:31 PM Suraksha Diagnostic acquires 63% equity shares in Fetomat Wellness 10 Apr, 2:10 PM Suraksha Diagnostic informs about press release 7 Mar, 5:33 PM Suraksha Diagnostic informs about resignation of CFO and KMP 17 Feb, 5:29 PM Suraksha Diagnostic - Quaterly Results 8 Feb, 6:20 PM Suraksha Diagnostic - Quaterly Results 8 Feb, 6:20 PM Suraksha Diagnostic - Quaterly Results 8 Feb, 6:20 PM Suraksha Diagnostic informs about board meeting 3 Feb, 2:29 PM Suraksha Diagnostic informs about closure of trading window 26 Dec, 12:33 PM Suraksha Diagnostic informs about newspaper publication 21 Dec, 3:48 PM Suraksha Diagnostic informs about investor presentation 21 Dec, 2:06 PM Suraksha Diagnostic informs about investors meet 21 Dec, 1:18 PM Suraksha Diagnostic - Quaterly Results 20 Dec, 7:05 PM Suraksha Diagnostic - Quaterly Results 20 Dec, 7:05 PM Suraksha Diagnostic informs about disclosure 9 Dec, 1:06 PM Suraksha Diagnostic coming with IPO to raise upto Rs 846 crore 28 Nov, 10:34 AM Suraksha Diagnostic gets Sebi's nod to float IPO 8 Oct, 12:24 PM

Suraksha Diagnostic Stock Price Analysis and Quick Research Report. Is Suraksha Diagnostic an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Suraksha Diagnostic and its performance over the period of time. Suraksha Diagnostic stock price today is Rs 314.25.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Suraksha Diagnostic cash from the operating activity was Rs 62.798 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Suraksha Diagnostic has a Debt to Equity ratio of 0.0272 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Suraksha Diagnostic , the EPS growth was -98.1831 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Suraksha Diagnostic has OPM of 33.4232587193501 % which is a good sign for profitability.
     
  • ROE: Suraksha Diagnostic have a average ROE of 17.0032 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Suraksha Diagnostic is Rs 314.25. One can use valuation calculators of ticker to know if Suraksha Diagnostic share price is undervalued or overvalued.
Last Updated on:
Brief about Suraksha Diagnostic
X